And Phase 2 data, while informative, may not perfectly predict Phase 3 outcomes
GLP-1 medications approved by the FDA are already part of Klinics offerings, and they help many achieve similar weight management outcomes
Heres what it can do: Supports gut health BPC-157 helps strengthen the stomach lining and has been shown to protect against ulcers, acid reflux, and leaky gut
Metformin : Improves insulin resistance, supports ovulation, and is considered safe during early pregnancy
Emerging types such as diabetes type 3, which is associated with Alzheimers disease, and type 4 and type 5, often linked to specific genetic or lifestyle factors, represent growing segments that are gaining attention from pharmaceutical companies